If corticosteroids are indicated in patients with latent tuberculosis or tuberculin reactivity, close observation is necessary since reactivation of the disease may occur
[1] The formulation delivers 17-estradiol in a depot that slowly releases hormone over several weeks, thereby potentially supporting more stable serum estrogen concentrations than daily oral or transdermal preparations and potentially improving symptom control for individuals with hypoestrogenism or menopausal vasomotor instability
Evaluate injection sites, titers, and if there is a loss of effect
Retrieved June 8, 2025, from Wagner, C
Monitor your progress closely and be willing to switch to injectable if oral results plateau or become inconsistent
4 Australian prevalence rates are estimated at 25%, 1 with elevated risk for Aboriginal and Torres Strait Islander women